Business Context and Reporting Period
This Form 8-K filing by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) covers events occurring on December 30, 2015, and January 4, 2016. The report details the entry into a material definitive loan agreement with Kreos Capital V (Expert Fund) Limited to secure financing for operations.
Key Financial Metrics and Debt Structure
- Total Credit Facility: $20.0 million line of credit.
- Initial Drawdown: $12.0 million drawn on January 4, 2016.
- Additional Availability: Up to $8.0 million available in tranches (minimum $2.0 million each) if the Company raises $10.0 million or more in equity/debt convertible to equity prior to December 31, 2016.
- Interest Rate: 10.75% per annum, payable monthly in arrears.
- Repayment Terms: Principal repayable monthly over 24 months, commencing 12 months after the drawdown date. The term extends to 36 months if the Company raises $20.0 million or more in equity/debt convertible to equity.
- Fees: 1.0% transaction fee on the total available line ($200,000) paid upon execution; 1.0% end-of-loan payment on each tranche drawn.
- Collateral: Security interest granted over all Company assets, including intellectual property and subsidiary equity interests.
Material Changes and Equity Implications
In connection with the loan agreement, the Company issued a warrant to Kreos with an aggregate value of $1.15 million. This warrant allows the purchase of up to 119,295 ordinary shares at an exercise price of $9.64 per share. If additional amounts are drawn down under the line of credit, the warrant amount will increase by 5.75% of any such additional drawdown.
Outlook, Risks, and Contingencies
The filing indicates a contingency for future liquidity: the ability to access the remaining $8.0 million of the credit line is contingent upon the Company successfully raising $10.0 million or more in capital prior to December 31, 2016. Additionally, the extension of the repayment period from 24 to 36 months is contingent on raising $20.0 million or more. The filing does not provide specific revenue, profit, or cash flow metrics for the period, as it focuses solely on the financing event.
Investor Verification Checklist
- Verify the Company's current cash position and immediate liquidity needs following the $12.0 million drawdown.
- Assess the feasibility of raising the required $10.0 million to $20.0 million in equity or convertible debt by December 31, 2016, to unlock additional funds and extend repayment terms.
- Review the impact of the 10.75% interest rate and associated fees on future operating expenses and net income.
- Examine the potential dilution impact of the warrant issuance (119,295 shares at $9.64) and potential increases if additional tranches are drawn.
- Confirm the status of the security interest granted over all assets, including intellectual property, and its implications for future financing or operations.